Studies in Apoe−/− and Ldlr−/− mice have provided evidence for the disease-restraining role for NAbs during atherosclerosis initiation and progression and provide researchers with the ability to dissect the cellular and molecular pathways mediating their production. This evidence concerns the gene LDLR and atherosclerosis.